Home › Upcoming votes › Lantern Pharma Inc.
The deadline as the proxy statement states it: “vote must be received by 11:59 p.m., Eastern Time on November 30, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in Lantern Pharma Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | Election of directors Director election |
Board | For | 6 nominees; support 98% to 99% |
| 2 | Increase authorized common stock to 50 million shares | Board | For | — |
| 3 | Amend 2018 Equity Incentive Plan (+250,000 shares) | Board | For | — |
| 4 | Issuance of shares upon exercise of purchase warrants | Board | For | — |
| 5 | Ratify EisnerAmper LLP as auditor Auditor |
Board | For | 99.4% support |
| 6 | Advisory vote on executive compensation Say on pay |
Board | For | — |
| 7 | Frequency of advisory votes on executive compensation Say-on-pay frequency |
Board | 1 year | — |
From Lantern Pharma Inc.’s Form 8-K, filed September 23, 2025, for the meeting held September 19, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Donald Jeff Keyser | 99% | Elected |
| Elect Director: Panna Sharma | 98% | Elected |
| Elect Director: Vijay Chandru | 98% | Elected |
| Elect Director: Maria Maccecchini | 99% | Elected |
| Elect Director: Lee T. Schalop | 99% | Elected |
| Elect Director: David S. Silberstein | 98% | Elected |
| Our stockholders approved the one-time repricing of certain stock options granted under the Second Amended and Restated Lantern Pharma Inc. | 66% | Approved |
| In addition, our stockholders ratified the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fisca | 99.4% | Approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.